Report Detail

Medical Devices & Consumables Global Insulin Delivery System Market Insights and Forecast to 2026

  • RnM4130893
  • |
  • 12 August, 2020
  • |
  • Global
  • |
  • 146 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Insulin Delivery System market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Insulin Delivery System market is segmented into
Insulin Syringes
Insulin PumpS
Insulin Pens

Segment by Application, the Insulin Delivery System market is segmented into
Hospitals
Home Care

Regional and Country-level Analysis
The Insulin Delivery System market is analysed and market size information is provided by regions (countries).
The key regions covered in the Insulin Delivery System market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Insulin Delivery System Market Share Analysis

Insulin Delivery System market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Insulin Delivery System by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Insulin Delivery System business, the date to enter into the Insulin Delivery System market, Insulin Delivery System product introduction, recent developments, etc.
The major vendors covered:
BD
Novo Nordisk
Sanofi
Eli Lilly
Medtronic
Animas
Beta Bionics
Cellnovo
Copernicus
Dance Biopharm
Debiotech
InsuJet
Insulet
MannKind
Owen Mumford
Roche
SHL
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed


1 Study Coverage

  • 1.1 Insulin Delivery System Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Insulin Delivery System Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Insulin Delivery System Market Size Growth Rate by Type
    • 1.4.2 Insulin Syringes
    • 1.4.3 Insulin PumpS
    • 1.4.4 Insulin Pens
  • 1.5 Market by Application
    • 1.5.1 Global Insulin Delivery System Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Home Care
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Insulin Delivery System Market Size, Estimates and Forecasts
    • 2.1.1 Global Insulin Delivery System Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Insulin Delivery System Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Insulin Delivery System Production Estimates and Forecasts 2015-2026
  • 2.2 Global Insulin Delivery System, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Insulin Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Insulin Delivery System Manufacturers Geographical Distribution
  • 2.4 Key Trends for Insulin Delivery System Markets & Products
  • 2.5 Primary Interviews with Key Insulin Delivery System Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Insulin Delivery System Manufacturers by Production Capacity
    • 3.1.1 Global Top Insulin Delivery System Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Insulin Delivery System Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Insulin Delivery System Manufacturers Market Share by Production
  • 3.2 Global Top Insulin Delivery System Manufacturers by Revenue
    • 3.2.1 Global Top Insulin Delivery System Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Insulin Delivery System Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Insulin Delivery System Revenue in 2019
  • 3.3 Global Insulin Delivery System Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Insulin Delivery System Production by Regions

  • 4.1 Global Insulin Delivery System Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Insulin Delivery System Regions by Production (2015-2020)
    • 4.1.2 Global Top Insulin Delivery System Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Insulin Delivery System Production (2015-2020)
    • 4.2.2 North America Insulin Delivery System Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Insulin Delivery System Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Insulin Delivery System Production (2015-2020)
    • 4.3.2 Europe Insulin Delivery System Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Insulin Delivery System Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Insulin Delivery System Production (2015-2020)
    • 4.4.2 China Insulin Delivery System Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Insulin Delivery System Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Insulin Delivery System Production (2015-2020)
    • 4.5.2 Japan Insulin Delivery System Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Insulin Delivery System Import & Export (2015-2020)

5 Insulin Delivery System Consumption by Region

  • 5.1 Global Top Insulin Delivery System Regions by Consumption
    • 5.1.1 Global Top Insulin Delivery System Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Insulin Delivery System Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Insulin Delivery System Consumption by Application
    • 5.2.2 North America Insulin Delivery System Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Insulin Delivery System Consumption by Application
    • 5.3.2 Europe Insulin Delivery System Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Insulin Delivery System Consumption by Application
    • 5.4.2 Asia Pacific Insulin Delivery System Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Insulin Delivery System Consumption by Application
    • 5.5.2 Central & South America Insulin Delivery System Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Insulin Delivery System Consumption by Application
    • 5.6.2 Middle East and Africa Insulin Delivery System Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Insulin Delivery System Market Size by Type (2015-2020)
    • 6.1.1 Global Insulin Delivery System Production by Type (2015-2020)
    • 6.1.2 Global Insulin Delivery System Revenue by Type (2015-2020)
    • 6.1.3 Insulin Delivery System Price by Type (2015-2020)
  • 6.2 Global Insulin Delivery System Market Forecast by Type (2021-2026)
    • 6.2.1 Global Insulin Delivery System Production Forecast by Type (2021-2026)
    • 6.2.2 Global Insulin Delivery System Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Insulin Delivery System Price Forecast by Type (2021-2026)
  • 6.3 Global Insulin Delivery System Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Insulin Delivery System Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Insulin Delivery System Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 BD
    • 8.1.1 BD Corporation Information
    • 8.1.2 BD Overview
    • 8.1.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 BD Product Description
    • 8.1.5 BD Related Developments
  • 8.2 Novo Nordisk
    • 8.2.1 Novo Nordisk Corporation Information
    • 8.2.2 Novo Nordisk Overview
    • 8.2.3 Novo Nordisk Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Novo Nordisk Product Description
    • 8.2.5 Novo Nordisk Related Developments
  • 8.3 Sanofi
    • 8.3.1 Sanofi Corporation Information
    • 8.3.2 Sanofi Overview
    • 8.3.3 Sanofi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Sanofi Product Description
    • 8.3.5 Sanofi Related Developments
  • 8.4 Eli Lilly
    • 8.4.1 Eli Lilly Corporation Information
    • 8.4.2 Eli Lilly Overview
    • 8.4.3 Eli Lilly Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Eli Lilly Product Description
    • 8.4.5 Eli Lilly Related Developments
  • 8.5 Medtronic
    • 8.5.1 Medtronic Corporation Information
    • 8.5.2 Medtronic Overview
    • 8.5.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Medtronic Product Description
    • 8.5.5 Medtronic Related Developments
  • 8.6 Animas
    • 8.6.1 Animas Corporation Information
    • 8.6.2 Animas Overview
    • 8.6.3 Animas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Animas Product Description
    • 8.6.5 Animas Related Developments
  • 8.7 Beta Bionics
    • 8.7.1 Beta Bionics Corporation Information
    • 8.7.2 Beta Bionics Overview
    • 8.7.3 Beta Bionics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Beta Bionics Product Description
    • 8.7.5 Beta Bionics Related Developments
  • 8.8 Cellnovo
    • 8.8.1 Cellnovo Corporation Information
    • 8.8.2 Cellnovo Overview
    • 8.8.3 Cellnovo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Cellnovo Product Description
    • 8.8.5 Cellnovo Related Developments
  • 8.9 Copernicus
    • 8.9.1 Copernicus Corporation Information
    • 8.9.2 Copernicus Overview
    • 8.9.3 Copernicus Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Copernicus Product Description
    • 8.9.5 Copernicus Related Developments
  • 8.10 Dance Biopharm
    • 8.10.1 Dance Biopharm Corporation Information
    • 8.10.2 Dance Biopharm Overview
    • 8.10.3 Dance Biopharm Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Dance Biopharm Product Description
    • 8.10.5 Dance Biopharm Related Developments
  • 8.11 Debiotech
    • 8.11.1 Debiotech Corporation Information
    • 8.11.2 Debiotech Overview
    • 8.11.3 Debiotech Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Debiotech Product Description
    • 8.11.5 Debiotech Related Developments
  • 8.12 InsuJet
    • 8.12.1 InsuJet Corporation Information
    • 8.12.2 InsuJet Overview
    • 8.12.3 InsuJet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 InsuJet Product Description
    • 8.12.5 InsuJet Related Developments
  • 8.13 Insulet
    • 8.13.1 Insulet Corporation Information
    • 8.13.2 Insulet Overview
    • 8.13.3 Insulet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.13.4 Insulet Product Description
    • 8.13.5 Insulet Related Developments
  • 8.14 MannKind
    • 8.14.1 MannKind Corporation Information
    • 8.14.2 MannKind Overview
    • 8.14.3 MannKind Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.14.4 MannKind Product Description
    • 8.14.5 MannKind Related Developments
  • 8.15 Owen Mumford
    • 8.15.1 Owen Mumford Corporation Information
    • 8.15.2 Owen Mumford Overview
    • 8.15.3 Owen Mumford Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.15.4 Owen Mumford Product Description
    • 8.15.5 Owen Mumford Related Developments
  • 8.16 Roche
    • 8.16.1 Roche Corporation Information
    • 8.16.2 Roche Overview
    • 8.16.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.16.4 Roche Product Description
    • 8.16.5 Roche Related Developments
  • 8.17 SHL
    • 8.17.1 SHL Corporation Information
    • 8.17.2 SHL Overview
    • 8.17.3 SHL Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.17.4 SHL Product Description
    • 8.17.5 SHL Related Developments
  • 8.18 SOOIL
    • 8.18.1 SOOIL Corporation Information
    • 8.18.2 SOOIL Overview
    • 8.18.3 SOOIL Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.18.4 SOOIL Product Description
    • 8.18.5 SOOIL Related Developments
  • 8.19 Tandem Diabetes Care
    • 8.19.1 Tandem Diabetes Care Corporation Information
    • 8.19.2 Tandem Diabetes Care Overview
    • 8.19.3 Tandem Diabetes Care Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.19.4 Tandem Diabetes Care Product Description
    • 8.19.5 Tandem Diabetes Care Related Developments
  • 8.20 Valeritas
    • 8.20.1 Valeritas Corporation Information
    • 8.20.2 Valeritas Overview
    • 8.20.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.20.4 Valeritas Product Description
    • 8.20.5 Valeritas Related Developments
  • 8.21 West Pharma
    • 8.21.1 West Pharma Corporation Information
    • 8.21.2 West Pharma Overview
    • 8.21.3 West Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.21.4 West Pharma Product Description
    • 8.21.5 West Pharma Related Developments
  • 8.22 Ypsomed
    • 8.22.1 Ypsomed Corporation Information
    • 8.22.2 Ypsomed Overview
    • 8.22.3 Ypsomed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.22.4 Ypsomed Product Description
    • 8.22.5 Ypsomed Related Developments

9 Insulin Delivery System Production Forecast by Regions

  • 9.1 Global Top Insulin Delivery System Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Insulin Delivery System Regions Forecast by Production (2021-2026)
  • 9.3 Key Insulin Delivery System Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Insulin Delivery System Consumption Forecast by Region

  • 10.1 Global Insulin Delivery System Consumption Forecast by Region (2021-2026)
  • 10.2 North America Insulin Delivery System Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Insulin Delivery System Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Insulin Delivery System Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Insulin Delivery System Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Insulin Delivery System Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Insulin Delivery System Sales Channels
    • 11.2.2 Insulin Delivery System Distributors
  • 11.3 Insulin Delivery System Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Insulin Delivery System Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Insulin Delivery System Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Insulin Delivery System Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on Insulin Delivery System. Industry analysis & Market Report on Insulin Delivery System is a syndicated market report, published as Global Insulin Delivery System Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Insulin Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,900.40
    5,850.60
    7,800.80
    4,552.10
    6,828.15
    9,104.20
    754,306.00
    1,131,459.00
    1,508,612.00
    409,199.00
    613,798.50
    818,398.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report